These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32529971)

  • 1. Advances in Studies on Neurodegenerative Diseases and their Treatments.
    Gupta SP
    Curr Top Med Chem; 2020; 20(13):2379. PubMed ID: 32529971
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural Products and Neuroprotection.
    Angeloni C; Vauzour D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Society for Neuroscience--34th annual meeting. Neurodegenerative disease and ion channel modulators. 23-27 October 2004, San Diego, CA, USA.
    Mackonochie M; Phillips T
    IDrugs; 2004 Dec; 7(12):1070-3. PubMed ID: 15599795
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases.
    Renaud J; Martinoli MG
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids as Promising Therapeutics of the Future: A Hub for Cells Survival or Death.
    Barreca D; Trombetta D
    Curr Med Chem; 2019; 26(27):5092-5093. PubMed ID: 31721692
    [No Abstract]   [Full Text] [Related]  

  • 6. Redox status and aging link in neurodegenerative diseases.
    Pérez de la Cruz V; Korrapati SV; Pedraza-Chaverrí J
    Oxid Med Cell Longev; 2014; 2014():270291. PubMed ID: 24778767
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric use of tetracyclines: focus on neurodevelopmental effects.
    Inta I; Hoffmann GF; Bettendorf M
    Pediatr Res; 2017 Nov; 82(5):725-726. PubMed ID: 28700569
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders.
    Volcho KP; Laev SS; Ashraf GM; Aliev G; Salakhutdinov NF
    Curr Med Chem; 2018; 25(39):5327-5346. PubMed ID: 28079000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox chemistry of green tea polyphenols: therapeutic benefits in neurodegenerative diseases.
    Hügel HM; Jackson N
    Mini Rev Med Chem; 2012 May; 12(5):380-7. PubMed ID: 22303970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective effects of curcumin].
    Li Y; Wang P
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3173-5. PubMed ID: 20352992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
    Ziemka-Nalecz M; Jaworska J; Sypecka J; Zalewska T
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):855-870. PubMed ID: 30165682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brief Review on the Neuroprotective Mechanisms of Vitexin.
    Lima LKF; Pereira SKS; Junior RDSS; Santos FPDS; Nascimento AS; Feitosa CM; Figuerêdo JS; Cavalcante ADN; Araújo ECDC; Rai M
    Biomed Res Int; 2018; 2018():4785089. PubMed ID: 30627560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.
    Kuboyama T; Tohda C; Komatsu K
    Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
    Hill J; Zawia NH
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.
    Calsolaro V; Edison P
    CNS Drugs; 2015 Dec; 29(12):1023-39. PubMed ID: 26666230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.
    Ludolph AC; Drory VE
    J Neurol; 2000 Dec; 247 Suppl 6():VI/1. PubMed ID: 19714407
    [No Abstract]   [Full Text] [Related]  

  • 17. Society for Neuroscience--34th annual meeting. Neuroprotection and anxiety. 23-27 October 2004, San Diego, CA, USA.
    Phillips T; Mackonochie M
    IDrugs; 2004 Dec; 7(12):1074-6. PubMed ID: 15599796
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases.
    Herrera-Arozamena C; Martí-Marí O; Estrada M; de la Fuente Revenga M; Rodríguez-Franco MI
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27598108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids and neurodegenerative diseases.
    Romero J; Orgado JM
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):440-50. PubMed ID: 19839933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.
    Li Y; Li L; Hölscher C
    CNS Drugs; 2016 Oct; 30(10):889-97. PubMed ID: 27395402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.